EMERGENCY EPINEPHRINE
Emergency Epinephrine Act
In 2013, the Georgia General Assembly authorized public and private schools to acquire and stock a supply of auto-injectable epinephrine, and to authorize trained lay personnel to administer epinephrine to students experiencing an anaphylactic reaction. To encourage schools to take advantage of the law, the legislature also granted immunity from civil liability for persons who choose in good faith to administer or not administer epinephrine in the school setting. Code Section 20-2-776.2.
In 2015, the Georgia General Assembly expanded this authorization to include an organization designated by the Georgia Department of Health as eligible to acquired and stock auto-injectable epinephrine. As with the previous school legislation, persons who are trained and designated by those organizations to administer epinephrine enjoy immunity from civil liability for their good faith decision to administer or not administer epinephrine. Code Section 31-1-15.
The Department of Public Health has designated the following types of organizations as eligible under Code Section 31-1-15 to acquire, stock, and administer auto-injectable epinephrine. To take advantage of the law, such organizations need only register with the Department as explained below.
List of organizations that are eligible to register:
Airport
Churches, Religious Institutions
City/County/State Government Offices
Colleges/Universities
Concert Venues
Daycare Centers
Entertainment Venues
Factories
Hotels/Motels/Resorts/Spas/Tourist Accommodations
Museums
Private/Corporate Offices
Recreation/Sports Camps
Restaurants
Scouting Units/Units and Districts
Shopping Malls
Sports Arenas
State Parks
Theme Parks/Water Parks
YMCA/YWCA
Youth Sports Leagues
Epinephrine Auto-Injector Products
Epinephrine
Adrenaclick® (Amedra Pharmaceuticals) is a "pen style" epinephrine auto-injector that delivers one dose of epinephrine per unit. It comes packaged as a two unit set and is available in both 0.15 and 0.3 mg doses. It has numbered and color-coded instructions. Adrenaclick® Training Video available.
Authorized Generic of Adrenaclick®- Epinephrine injection, USP Auto-Injector (Lineage Therapeutics) Epinephrine injection, and USP auto-injector provide an emergency injection of epinephrine for the treatment of anaphylaxis. This product is available in 0.15 and 0.3 mg doses and features numbered and color-coded instructions. It is designed for single-dose use by patients and caregivers in an anaphylactic emergency. A training video is available.
Epi-Pen® Auto-injector (Mylan Specialty L.P) -EpiPen® and EpiPen Jr Auto-Injectors (0.3 and 0.15 mg epinephrine) are used for the injection of epinephrine, the first-line treatment for life-threatening allergic reactions (anaphylaxis). Coupons may be available on the website and from the manufacturer. A training video is available.
Online Demonstration Videos - Administration of Epinephrine Auto-Injectors
How to use the Epi-Pen® and EpiPen Jr®
https://www.epipen.com/en/about-epipen/how-to-use-epipen
How to use the Auvi-Q™ (epinephrine injection)
http://www.auvi-q.com/auvi-q-demo
http://products.sanofi.us/Auvi-Q_Patient_Information/Trainer_Informatio…
How to use the Adrenaclick™
http://www.adrenaclick.com/how_to_use_adrenaclick_epinephrine_injection…
Anaphylaxis and Epinephrine Auto-Injector - Online Courses
This online course will teach you the signs and symptoms of anaphylaxis and how to care for a person having a severe allergic reaction, including how to administer epinephrine using an auto-injector device. The course, which includes videos, activities that reinforce key information and a learning assessment, will take approximately 30 minutes to complete. Upon registration, you will receive an email with information on how you can request a free EpiPen® (epinephrine) Auto-Injector training device.
EpiExpert - Allergy Responder Training™
This online course prepares individuals and groups to respond to anaphylaxis with clear, comprehensive online training and certification. Once trained, Allergy Responders™ have a thorough background in the recognition and response to allergic emergencies. These individuals will respond to anaphylaxis – severe allergic reaction, with assessment and injection of life-saving epinephrine administered using auto-injectors included in the Allergy Crisis Kits. The Allergy Responder training is a 1year certification following guidelines and directives created by EpiExpert and the World Allergy Organization.
LifeReach Online Training and Certification
LifeReach Training and Certification Program for Anaphylaxis. This training program is written to educate the general public on recognizing and responding to anaphylaxis.
Resources
This toolkit was developed to assist the physician when responding to requests for a prescription. The toolkit contains a letter from Dr. Brenda Fitzgerald, Commissioner of Public Health, an explanation of the Emergency Epinephrine Act, and a standardized Epinephrine Prescription Request Form.
Implementation
The information included contains basic information on medication location, storage and disposal of auto-injectors as well as Food and Allergy Resources.
Emergency Epinephrine Registry
Any organization seeking to acquire, stock and administer epinephrine auto-injector must register with the department. Once registration is complete, you will receive a unique identification number, an Emergency Epinephrine Identification Number (EEI# 123). This number should be kept on file.
Following administration of the stock epinephrine auto–injectable, your organization will need to complete an online form, the Epinephrine Administration Report. Completion of this form will allow the department to monitor the incidence and details of Emergency Epinephrine administration in Georgia. You will need the emergency identification number to submit the report. Upon completion and submission of this form, you will have the opportunity to print a copy for your own records.
Please forward any questions related to Emergency Epinephrine to the e-mail address: [email protected].
Click here to access the registry and/or the state report.
Page last updated 04/18/2017